BamSEC and AlphaSense Join Forces
Learn More

ProPhase Labs Inc.

NASDAQ: PRPH    
Share price (8/8/25): $0.31    
Market cap (8/8/25): $13.0 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 8-K 3 pages Instruction to Reserve Shares
12/34/56
EX-10.5
from 8-K 25 pages Security Agreement
12/34/56
EX-10.4
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 22 pages Common Share Purchase Warrant ProPhase Labs, Inc
12/34/56
EX-10.2
from 8-K 30 pages ProPhase Labs, Inc. 20% Oid Senior Secured Convertible Note
12/34/56
EX-10.1
from 8-K 30 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 8 pages ProPhase Labs, Inc. Inducement Option Award Agreement
12/34/56
EX-10.1
from 8-K 2 pages Certain Personally Identifiable Information Has Been Omitted From This Exhibit Pursuant to Item 601(a)(6) of Regulation S-K. [***] Indicates That Information Has Been Redacted
12/34/56
EX-10.1
from 8-K 68 pages Common Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages Amended and Restated Unsecured Promissory Note and Guaranty
12/34/56
EX-10.1
from 8-K/A 8 pages ProPhase Labs, Inc. Inducement Option Award Agreement
12/34/56
EX-10.1
from 8-K 3 pages Standstill Agreement
12/34/56
EX-10.5
from 10-K 4 pages ProPhase Labs, Inc. 2022 Equity Compensation Plan Option Award Agreement
12/34/56
EX-10.4
from 10-K 6 pages ProPhase Labs, Inc. 2022 Equity Compensation Plan Options Award Agreement
12/34/56
EX-10.3
from 10-K 4 pages ProPhase Labs, Inc. 2022 Directors’ Equity Compensation Plan Option Award Agreement
12/34/56
EX-10.1
from 8-K 2 pages Certain Personally Identifiable Information Has Been Omitted From This Exhibit Pursuant to Item 601(a)(6) of Regulation S-K. [***] Indicates That Information Has Been Redacted. December 27, 2023 Jed Latkin [***] Offer and Terms of Employment
12/34/56
EX-10.2
from 8-K 9 pages The ProPhase Labs, Inc. Amended and Restated 2022 Directors’ Equity Compensation Plan
12/34/56
EX-10.1
from 8-K 9 pages The ProPhase Labs, Inc. Amended and Restated 2022 Equity Compensation Plan
12/34/56
EX-10.6
from 10-K 4 pages ProPhase Labs, Inc. 2022 Directors’ Equity Compensation Plan Option Award Agreement
12/34/56
EX-10.5
from 10-K 6 pages ProPhase Labs, Inc. 2022 Equity Compensation Plan Options Award Agreement
12/34/56